Correlation Between Bone Biologics and Cellink AB

Can any of the company-specific risk be diversified away by investing in both Bone Biologics and Cellink AB at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bone Biologics and Cellink AB into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bone Biologics Corp and Cellink AB, you can compare the effects of market volatilities on Bone Biologics and Cellink AB and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bone Biologics with a short position of Cellink AB. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bone Biologics and Cellink AB.

Diversification Opportunities for Bone Biologics and Cellink AB

0.4

Correlation Coefficient

Bone Biologics  Cellink AB

Very weak diversification

The 3 months correlation between Bone and Cellink is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Bone Biologics Corp and Cellink AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cellink AB and Bone Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bone Biologics Corp are associated (or correlated) with Cellink AB. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cellink AB has no effect on the direction of Bone Biologics i.e., Bone Biologics and Cellink AB go up and down completely randomly.

Pair Corralation between Bone Biologics and Cellink AB

Assuming the 90 days horizon Bone Biologics Corp is expected to generate 6.72 times more return on investment than Cellink AB. However, Bone Biologics is 6.72 times more volatile than Cellink AB. It trades about 0.05 of its potential returns per unit of risk. Cellink AB is currently generating about 0.16 per unit of risk. If you would invest  3,050  in Bone Biologics Corp on December 29, 2024 and sell it today you would lose (1,030) from holding Bone Biologics Corp or give up 33.77% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	46.03%
Values	Daily Returns

Bone Biologics Corp  vs.  Cellink AB

Bone Biologics Corp

Risk-Adjusted Performance

Insignificant

Over the last 90 days Bone Biologics Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly fragile technical and fundamental indicators, Bone Biologics showed solid returns over the last few months and may actually be approaching a breakup point.

Cellink AB

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Cellink AB are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile forward-looking signals, Cellink AB reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Bone Biologics and Cellink AB

The main advantage of trading using opposite Bone Biologics and Cellink AB positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bone Biologics position performs unexpectedly, Cellink AB can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cellink AB will offset losses from the drop in Cellink AB's long position.

The idea behind Bone Biologics Corp and Cellink AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.